Tang WJ, An YF, Dai RX, Wang QH, Jiang LP, Tang XM, Yang XQ, Yu J, Tu WW, Zhao XD. Clinical, molecular, and T cellsubset analyses in a smallcohort of Chinese patients with hyper-IgM syndrome type Hum Immunol. 2014; 75(7):633-40. PubMed | Google Scholar

Madkaikar M, Gupta M, Chavan S, Italia K, Desai M, Merchant R, Radhakrishnan N, Ghosh K. X-linked hyper IgM syndrome: clinical, immunological and molecularfeatures in patients fromIndia. Blood Cells Mol Dis. 2014; 53(3):99-104. PubMed | Google Scholar

Rosen FS, Kevy SV, Merler E, Janeway CA, Gitlin D.Recurrentbacterial infections and dysgamma-globulinemia: deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins: report of two cases. Pediatrics. 1961; 28:182-95. PubMed | Google Scholar

Etzioni A, Ochs HD. The hyper IgM syndrome--an evolving story. PediatrRes. 2004; 56(4):519-25. PubMed | Google Scholar

Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. The X-linked hyper-IgM syndrome: clinical and immunologicfeatures of 79 patients. Medicine. 2003; 82(6):373-84. PubMed | Google Scholar

Minegishi Y, Lavoie A, Cunningham-Rundles C, Bédard PM, Hébert J, Côté L, Dan K, Sedlak D, Buckley RH, Fischer A, Durandy A, Conley ME. Mutations in activation-inducedcytidine deaminase in patients with hyper IgM syndrome. Clin Immunol. 2000;97(3):203-10. PubMed | Google Scholar

Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005 ;105(5):1881-90. PubMed | Google Scholar

Abolhassani H, Akbari F, Mirminachi B, Bazregari S, Hedayat E, Rezaei N, AghamohammadiA.Morbidity and mortality of Iranian patients with hyper IgM syndrome: a clinical analysis. Iran J Immunol. 2014 ; 11(2):123-33. PubMed | Google Scholar

Lee WI, Huang JL, Yeh KW, Yang MJ, Lai MC, Chen LC, Ou LS, Yao TC, Lin SJ, Jaing TH, Chen SH, Hsieh MY, Yu HH, Chien YH, Shyur SD. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype. Pediatr Infect Dis J. 2013 ;32(9):1010-6. PubMed | Google Scholar

Mellouli F, Mustapha IB, Khaled MB, Besbes H, Ouederni M, Mekki N, Ali MB, Larguèche B, Hachicha M, Sfar T, GueddicheN,Barsaoui S, Sammoud A, Boussetta K, Becher SB, Meherzi A, Guandoura N, Boughammoura L, Harbi A, Amri F, Bayoudh F, Jaballah NB, Tebib N, Bouaziz A, Mahfoudh A, Aloulou H, Mansour LB, Chabchoub I, Boussoffara R, Chemli J, Bouguila J, Hassayoun S, Hammami S, Habboul Z, Hamzaoui A, Ammar J, Barbouche MR, Bejaoui M. Report of the Tunisian Registry of Primary Immunodeficiencies: 25 Years of Experience (1988-2012). J Clin Immunol. 2015; 35(8):745-53. PubMed | Google Scholar

Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, Kili A, Benmiloud S, Benhsaien I, Faiz I, Maataoui O, Aadam Z, Aglaguel A, Baba LA, Jouhadi Z, Abilkassem R, Bouskraoui M, Hida M, Najib J, Alj HS. First report on the Moroccanregistry of primaryimmunodeficiencies: 15 years of experience (1998-2012). J Clin Immunol. 2014 May;34(4):459-68. PubMed | Google Scholar

Lamia S, Aloulou H, Kamoun T, Chabchoub I, Ben Moustapha I, Barbouch R, Mongia H. [Primaryimmunodeficiencydisorders in 51 cases]. Tunis Med. 2013; 91(1):38-43. PubMed | Google Scholar

Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000; 102(5):565-575. PubMed | Google Scholar

Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, EtzioniA,Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD. Clinicalspectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997; 131(1 Pt 1):47-54. PubMed | Google Scholar

Karaca NE, Forveille M, Aksu G, Durandy A, Kutukculer N. Hyper-immunoglobulin M syndrome type 3 with normal CD40 cell surface expression. Scand J Immunol. 2012; 76(1):21-5. PubMed | Google Scholar

Durandy A, Revy P, Imai K, Fischer A. Hyper immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. ImmunolRev. 2005; 203:67-79. PubMed | Google Scholar

Lopez-Granados E, Temmerman ST, Wu L, Reynolds JC, Follmann D, Liu S, Nelson DL, Rauch F, Jain A. Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis. Proc NatlAcadSci U S A. 2007; 104(12):5056-61. PubMed | Google Scholar

Quartier P, Bustamante J, Sanal O, Plebani A, Debré M, Deville A, Litzman J, Levy J, Fermand JP, Lane P, Horneff G, Aksu G, Yalçin I, Davies G, TezcanI,Ersoy F, Catalan N, Imai K, Fischer A, Durandy A. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin Immunol. 2004; 110(1):22-9. PubMed | Google Scholar

Durandy A, Kracker S. The Hyper IgM Syndromes–a Long List of Genes and Years of Discovery. Elsevier AcademicPress. 2014;198-210. PubMed | Google Scholar